Writing a check for a patient advocacy group is not enough. There are no shortcuts when it comes to true patient centricity. Some companies still think that writing a check to a patient advocacy organization and/or publicly supporting disease days makes them a patient-centric organization. These things are important, but it’s not enough. Being patient-centric means building a genuine working relationship with…
Read MoreCustomized managed access, compassionate use, expanded access and named patient programs designed for rare disease therapies, guided by real world evidence and data.
Does your rare disease commercial strategy need Managed Access expertise to guide your expansion planning?
RareiTi- a different kind of managed access company.
